FABP3 (Fatty Acid Binding Protein 3) - Biomarker
Overview
flowchart TD
biomarkers_fabp3_fatty_acid_bi["FABP3 Fatty Acid Binding Protein 3 - Biomarker"]
biomarkers_fabp3_fatty_acid_bi["Biomarker"]
biomarkers_fabp3_fatty_acid_bi -->|"related to"| biomarkers_fabp3_fatty_acid_bi
style biomarkers_fabp3_fatty_acid_bi fill:#81c784,stroke:#333,color:#000
biomarkers_fabp3_fatty_acid_bi["also"]
biomarkers_fabp3_fatty_acid_bi -->|"related to"| biomarkers_fabp3_fatty_acid_bi
style biomarkers_fabp3_fatty_acid_bi fill:#81c784,stroke:#333,color:#000
biomarkers_fabp3_fatty_acid_bi["known"]
biomarkers_fabp3_fatty_acid_bi -->|"related to"| biomarkers_fabp3_fatty_acid_bi
style biomarkers_fabp3_fatty_acid_bi fill:#81c784,stroke:#333,color:#000
biomarkers_fabp3_fatty_acid_bi["Heart-type"]
biomarkers_fabp3_fatty_acid_bi -->|"related to"| biomarkers_fabp3_fatty_acid_bi
style biomarkers_fabp3_fatty_acid_bi fill:#81c784,stroke:#333,color:#000
style biomarkers_fabp3_fatty_acid_bi fill:#4fc3f7,stroke:#333,color:#000
FABP3 (Fatty Acid Binding Protein 3), also known as Heart-type Fatty Acid Binding Protein (H-FABP), is a cytoplasmic protein expressed primarily in cardiac and skeletal muscle, as well as in neurons. In the context of neurodegeneration, FABP3 serves as a biomarker for neuronal injury and has shown utility in detecting neuronal damage in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
Properties
...FABP3 (Fatty Acid Binding Protein 3) - Biomarker
Overview
Mermaid diagram (expand to render)
FABP3 (Fatty Acid Binding Protein 3), also known as Heart-type Fatty Acid Binding Protein (H-FABP), is a cytoplasmic protein expressed primarily in cardiac and skeletal muscle, as well as in neurons. In the context of neurodegeneration, FABP3 serves as a biomarker for neuronal injury and has shown utility in detecting neuronal damage in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
Properties
| Property | Value |
|----------|-------|
| Category | Neuronal Injury Biomarker |
| Target | Neuronal Damage / Cell Death |
| Sample Type | CSF, Blood (serum/plasma) |
| Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Stroke, TBI |
| Normal Range | CSF: 0.5-2 ng/mL; Serum: 2-6 ng/mL |
Molecular Biology
Structure and Function
FABP3 is a small cytosolic protein (~15 kDa) belonging to the FABP family:
- Structure: Beta-barrel structure with hydrophobic core
- Function: Binds long-chain fatty acids, retinoic acid, and other lipids
- Expression: Heart, skeletal muscle, brain (neurons), kidney
Brain Expression
In the central nervous system:
- Primary expression: Neurons (pyramidal cells, Purkinje cells)
- Regional distribution: High in cortex, hippocampus, cerebellum
- Function in brain: Lipid transport, synaptic plasticity, neuroprotection
Release Mechanism
FABP3 is released into extracellular space upon:
- Necrosis — cell membrane rupture
- Apoptosis — controlled release from dying cells
- Exocytosis — active release under certain conditions
- Membrane permeability — increased permeability during injury
Role in Disease
Alzheimer's Disease
In AD, FABP3 is elevated and reflects synaptic and neuronal loss:
- CSF levels elevated in AD vs. controls
- Correlates with cognitive decline — higher levels = worse performance
- Predicts progression — high baseline predicts MCI→AD conversion
- Combined with other biomarkers — enhances diagnostic accuracy
Parkinson's Disease
In PD:
- Elevated in early PD — potential early marker
- Correlates with motor severity — UPDRS scores
- Cognitive impairment — higher in PD-MCI and PDD
- Disease progression — levels increase with disease duration
Amyotrophic Lateral Sclerosis (ALS)
In ALS:
- Markedly elevated in CSF compared to controls
- Correlates with disease progression — faster progressors have higher levels
- Motor neuron injury — reflects ongoing degeneration
- Prognostic utility — baseline predicts survival
Other Conditions
- Stroke — marker of acute neuronal injury
- Traumatic Brain Injury (TBI) — biomarker for severity
- Epilepsy — seizure-related neuronal damage
Clinical Applications
Diagnostic Utility
FABP3 shows moderate diagnostic utility:
| Comparison | Sensitivity | Specificity | AUC |
|------------|-------------|-------------|-----|
| AD vs. Controls | 65-75% | 60-70% | 0.70-0.78 |
| PD vs. Controls | 60-70% | 55-65% | 0.65-0.75 |
| ALS vs. Controls | 75-85% | 70-80% | 0.80-0.88 |
Prognostic Value
- AD progression — high FABP3 predicts faster MMSE decline
- PD progression — correlates with UPDRS progression
- ALS survival — higher levels associated with shorter survival
Best Use Cases
FABP3 is most useful as a complementary biomarker:
- Combined with Aβ42/40 for AD
- Combined with α-synuclein for PD
- Combined with NfL) for ALS
Detection Methods
| Method | Advantages | Limitations |
|--------|------------|-------------|
| ELISA | Standard method, high specificity | Moderate sensitivity |
| Simoa | Ultra-sensitive, low sample volume | Limited availability |
| Mass Spectrometry | High specificity, multi-analyte | Complex, expensive |
Sample Handling
- CSF: Collect via LP, store at -80°C, single freeze-thaw preferred
- Serum/Plasma: Collect in serum separator tubes, centrifuge within 1 hour
- Timing: Morning collection preferred (diurnal variation possible)
Comparison with Other Biomarkers
FABP3 is one of several neuronal injury biomarkers:
| Biomarker | Primary Source | Best For |
|-----------|---------------|----------|
| NfL | Axonal degeneration | ALS, MS, FTD |
| Neurogranin | Synaptic loss | AD |
| FABP3 | Neuronal injury | AD, PD, ALS |
| Tau | Axonal damage | AD |
| UCH-L1 | Neuronal death | TBI, stroke |
FABP3 complements these markers by providing unique insight into neuronal membrane integrity.
Therapeutic Implications
While FABP3 is primarily a biomarker, it informs therapeutic development:
- Neuroprotective strategies — reduced FABP3 = neuronal protection
- Disease monitoring — tracks treatment response
- Trial enrichment — high levels may indicate more aggressive disease
Cross-Linking
FABP3 is linked to the following topics:
- Alzheimer's Disease Biomarkers
- Parkinson's Disease Biomarkers
- Neurofilament Light Chain
- Neurogranin
- CSF Biomarkers
- Neuronal Injury Pathway
Background
The study of Fabp3 (Fatty Acid Binding Protein 3) Biomarker has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Allen Brain Atlas Resources
- [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
- [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
References
<sup><a href=#references>[1]</a></sup> Shimizu T, et al. Heart-type fatty acid binding protein as a biomarker for Alzheimer's disease. J Neurol Sci. 2018;390:98-102.
<sup><a href=#references>[2]</a></sup> Chiasserini D, et al. CSF biomarkers for neuronal damage in neurodegenerative disorders. J Alzheimers Dis. 2018;64(2):447-458.
<sup><a href=#references>[3]</a></sup> Bjerke M, et al. Cerebrospinal fluid FABP3 in Alzheimer's disease. Neurobiol Aging. 2019;79:58-67.
<sup><a href=#references>[4]</a></sup> Parnetti L, et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative diseases. Nat Rev Neurol. 2021;17(4):215-232.
<sup><a href=#references>[5]</a></sup> Constant O, et al. Cerebrospinal fluid FABP3 in Parkinson's disease. Mov Disord. 2020;35(12):2187-2195.
<sup><a href=#references>[6]</a></sup> Wilhelmus MM, et al. Fatty acid binding proteins in ALS. Neurology. 2017;89(9):913-921.
<sup><a href=#references>[7]</a></sup> Zetterberg H, et al. Neurological biomarkers. Nat Rev Neurol. 2019;15(9):543-558.
<sup><a href=#references>[8]</a></sup> Blennow K, et al. Cerebrospinal fluid biomarkers in neurodegenerative diseases. Lancet Neurol. 2020;19(2):140-148.
- Alzheimer's Disease Biomarkers
- Parkinson's Disease Biomarkers
- Neurofilament Light Chain
- Neurogranin
- CSF Biomarkers Overview
- ALS Biomarkers
External Links
- [FABP3 Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/2169)
- [FABP3 UniProt](https://www.uniprot.org/uniprot/P15090)
- [Alzheimer's Disease Neuroimaging Initiative (ADNI)](https://adni.loni.usc.edu)